National Drug Strategy
National Drug Strategy

National Amphetamine-Type Stimulant Strategy 2008-2011

3. Priority Areas

prev pageTOC |next page

Priority Area 1: Community awareness and understanding of amphetamine-type stimulant use and related problems
Priority Area 2: The supply of amphetamine-type stimulants
Priority Area 3: The use of amphetamine-type stimulants
Priority Area 4: Problems associated with amphetamine-type stimulant use
Priority Area 5: Organisational and system capacity to prevent and respond to amphetamine-type stimulant problems

prev pageTOC |next page